JOP20190137A1 - مستحضر لطب العيون - Google Patents
مستحضر لطب العيونInfo
- Publication number
- JOP20190137A1 JOP20190137A1 JOP/2019/0137A JOP20190137A JOP20190137A1 JO P20190137 A1 JOP20190137 A1 JO P20190137A1 JO P20190137 A JOP20190137 A JO P20190137A JO P20190137 A1 JOP20190137 A1 JO P20190137A1
- Authority
- JO
- Jordan
- Prior art keywords
- preparation
- ophthalmologic
- water soluble
- ophtalmologic
- fibrous carrier
- Prior art date
Links
- 239000007787 solid Substances 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229920003170 water-soluble synthetic polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
يتعلق الاختراع الحالي بوصف مستحضر خاص بالعيون خاصة لعلاج أمراض العيون واضطراباتها والوقاية من ذلك. ويكون هذا المستحضر الخاص بطب العيون في شكل حامل ليفي صلب يشتمل على ألياف قابلة للذوبان في الماء تحتوي على حمض الهيالورونيك أو ملح مقبول صيدلانيًا منه أو مشتق منه، وتحتوي على البوليمر الصناعي القابل للذوبان في الماء والعامل النشط والحامل الليفي الصلب الذي يذوب عند ملامسته للعين
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2016-827A CZ2016827A3 (cs) | 2016-12-23 | 2016-12-23 | Oftalmologický prostředek |
Publications (1)
Publication Number | Publication Date |
---|---|
JOP20190137A1 true JOP20190137A1 (ar) | 2019-06-11 |
Family
ID=61070241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2019/0137A JOP20190137A1 (ar) | 2016-12-23 | 2017-06-16 | مستحضر لطب العيون |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3558264B1 (ar) |
KR (1) | KR102511776B1 (ar) |
AR (1) | AR110433A1 (ar) |
BR (1) | BR112019012758A2 (ar) |
CZ (1) | CZ2016827A3 (ar) |
JO (1) | JOP20190137A1 (ar) |
MX (1) | MX2019007485A (ar) |
WO (1) | WO2018113805A1 (ar) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ202132A3 (cs) * | 2021-01-26 | 2022-04-20 | Contipro A.S. | Prostředek pro hojení ran, způsob jeho výroby a použití |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
JP2855307B2 (ja) * | 1992-02-05 | 1999-02-10 | 生化学工業株式会社 | 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法 |
IT1296689B1 (it) * | 1997-11-06 | 1999-07-14 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico aventi proprieta viscoelastiche e loro uso in campo biomedico-sanitario |
US7638137B2 (en) | 2002-06-05 | 2009-12-29 | University Of Florida Research Foundation, Incorporated | Ophthalmic drug delivery system |
US20130136784A1 (en) | 2007-10-11 | 2013-05-30 | Robert J. Staab | Methods for delivery of medication using dissolvable devices |
US8361492B2 (en) | 2008-04-29 | 2013-01-29 | Ocugenics, LLC | Drug delivery system and methods of use |
CA2735173C (en) * | 2008-09-02 | 2017-01-10 | Tautona Group Lp | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US20110229551A1 (en) | 2010-03-17 | 2011-09-22 | Notus Laboratories, Inc. | Drug delivery compositions and methods using nanofiber webs |
WO2013171764A2 (en) | 2012-04-30 | 2013-11-21 | Rubicon Research Private Limited | Ophthalmic formulations |
CZ304303B6 (cs) * | 2012-11-27 | 2014-02-19 | Contipro Biotech S.R.O. | Vlákna založená na hydrofobizovaném hyaluronanu, způsob jejich přípravy a použití, textilie na jejich bázi a použití |
CZ304654B6 (cs) * | 2012-11-27 | 2014-08-20 | Contipro Biotech S.R.O. | Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití |
CZ2013914A3 (cs) * | 2013-11-21 | 2015-02-25 | Contipro Biotech S.R.O. | Nanovlákna obsahující fototvrditelný esterový derivát kyseliny hyaluronové nebo její soli, fototvrzená nanovlákna, způsob jejich syntézy, přípravek obsahující fototvrzená nanovlákna a jejich použití |
EP3108874A1 (en) * | 2015-06-26 | 2016-12-28 | TRB Chemedica AG | Ophthalmologic pharmaceutical composition |
-
2016
- 2016-12-23 CZ CZ2016-827A patent/CZ2016827A3/cs unknown
-
2017
- 2017-06-16 JO JOP/2019/0137A patent/JOP20190137A1/ar unknown
- 2017-12-22 WO PCT/CZ2017/050066 patent/WO2018113805A1/en unknown
- 2017-12-22 BR BR112019012758A patent/BR112019012758A2/pt unknown
- 2017-12-22 KR KR1020197021449A patent/KR102511776B1/ko active IP Right Grant
- 2017-12-22 AR ARP170103643A patent/AR110433A1/es unknown
- 2017-12-22 MX MX2019007485A patent/MX2019007485A/es unknown
- 2017-12-22 EP EP17837847.7A patent/EP3558264B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
CZ307158B6 (cs) | 2018-02-07 |
MX2019007485A (es) | 2019-08-29 |
RU2019122292A (ru) | 2021-01-26 |
AR110433A1 (es) | 2019-03-27 |
KR20190099495A (ko) | 2019-08-27 |
EP3558264B1 (en) | 2024-07-17 |
RU2019122292A3 (ar) | 2021-03-17 |
WO2018113805A1 (en) | 2018-06-28 |
EP3558264A1 (en) | 2019-10-30 |
CZ2016827A3 (cs) | 2018-02-07 |
KR102511776B1 (ko) | 2023-03-17 |
BR112019012758A2 (pt) | 2019-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4279064A3 (en) | Drug delivery from hydrogels | |
PH12015502773A1 (en) | Methods for treating or preventing opthalmological conditions | |
MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
MA39767A (fr) | Solution aqueuse ophtalmique et méthode de traitement du syndrome de l'oeil sec | |
MX2022007221A (es) | Compuestos y composiciones para el tratamiento o prevencion de trastornos patologicos asociados con exceso de deposicion de fibrina y/o formacion de trombos. | |
WO2015171610A3 (en) | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease | |
BR112017002637A2 (pt) | métodos para tratar ou prevenir condições oftalmológicas | |
AR088585A1 (es) | Un medicamento para tratar la enfermedad del ojo anterior | |
EP4324454A3 (en) | Cross-linking agents and associated methods | |
PH12017502155A1 (en) | Formation of cyclosporin a/cyclodextrin nanoparticles | |
MY199237A (en) | Methods of treating ocular conditions | |
TN2015000356A1 (en) | Bicyclic compounds | |
MX2019008124A (es) | Metodos para el tratamiento de trastornos neurologicos. | |
EA202191684A1 (ru) | Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии | |
MX2017004760A (es) | Formulacion esterilizada por calor que comprende quitosan y proceso para preparacion de la misma. | |
MX357888B (es) | Sales basicas de adicion de nitroxolina y usos de las mismas. | |
MX2019007485A (es) | Preparacion oftalmologica. | |
WO2014117010A3 (en) | Composition for ophthalmic administration | |
MX2019011925A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
MY193529A (en) | Ophthalmologic pharmaceutical composition | |
WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
WO2014182696A3 (en) | Bioresorbable scaffold for neurologic drug delivery | |
MX2018004779A (es) | Uso terapeutico de una solucion oftalmica acuosa esteril. | |
GEP20207144B (en) | Ophthalmic composition comprising a synergistic combination of glycogen and hyaluronic acid or a salt thereof | |
MX2018005453A (es) | Uso terapeutico de una solucion oftalmica acuosa esteril. |